Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Disitamab Vedotin, Tunlametinib, and a PD-1 antibody for advanced gastric adenocarcinoma; the study i…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer [Phase 4]
Phase 4 trial evaluating genetic analysis-guided dosing of irinotecan within mFOLFIRINOX for locally advanced gastroesophageal and stomach c…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating the adverse events, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, leucovorin, a…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating the addition of Paclitaxel administered intraperitoneally with standard chemotherapy for gastric ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body [Phase 3]
A Phase 3 trial is evaluating whether adding radiotherapy to standard chemotherapy improves outcomes for patients with metastatic esophageal…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Multicentre Prospective Cohort Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
A multicenter prospective cohort study in India evaluating the gastric precancerous epithelial pathway using high-definition endoscopy and h…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]
Phase 1 clinical trial update for AVA6103 in patients with locally advanced or metastatic selected solid tumors; the study is currently recr…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating SHR-1701 with or without apatinib plus chemotherapy as neoadjuvant therapy for gastric adenocarc…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Magnetic Sentinel Lymph Node Mapping in Gastric Cancer [Phase 1]
Phase 1 clinical trial evaluating magnetic sentinel lymph node mapping for staging in gastric adenocarcinoma; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels [Phase 2]
Phase 2 Yale-sponsored trial evaluating adding sequential cytoreductive intervention to standard-of-care therapy for metastatic foregut aden…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer [NA]
A clinical trial update describes assessing adherence to remotely monitored physical activity via a smartwatch and its potential to reduce f…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin and liposomal irinotecan with trastuzumab for HER2-positive disease in advanced esophageal a…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma
This clinical trial update describes a real-world study of zolbetuximab in patients with HER-2 negative, Claudin-18.2–positive metastatic ga…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating perioperative chemotherapy with low-dose radiotherapy and tislelizumab for locally advanced gastric or gastroesopha…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction [Phase 1]
A Phase 1 study of IM96 CAR-T Cell Therapy for advanced gastric adenocarcinoma and esophagogastric junction adenocarcinoma. The trial status…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]
Phase 1 study update for NRM-823 in locally advanced or metastatic refractory solid tumors, currently recruiting. The trial lists head and n…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma [Phase 3]
A Phase III clinical trial is evaluating Cadonilimab in combination with the SOX chemotherapy regimen as perioperative treatment for patient…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma
The study, sponsored by Nanfang Hospital and Southern Medical University, is evaluating an artificial intelligence model to aid Claudin18.2 …
-
CLINICAL_TRIALS other · 2026-02-03Clinical Trial Update: SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis [Phase 2]
Phase 2 trial evaluating SHR-1701 in combination with chemotherapy for gastric adenocarcinoma or gastroesophageal junction adenocarcinoma wi…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study Collecting Health Information to Understand and Prevent Gastric Cancer
This recruiting clinical trial, sponsored by Memorial Sloan Kettering Cancer Center, seeks to collect health information to understand and p…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu [EARLY_Phase 1]
Early-phase trial update on ProofPrincip intra-tumoral T cells with a single-dose checkpoint inhibitor for gastroesophageal adenocarcinoma w…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with trastuzumab and chemotherapy for patients with esophagogastric cancer.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Registry Platform Gastric/Esophageal Cancer (SAPHIR)
This Clinical Trial Update reports an ongoing registry platform trial SAPHIR addressing gastric and esophageal cancers, currently recruiting…